SEC Amends Final Rules on Executive and Director Compensation Disclosure
02 January 2007
On December 22, 2006, the Securities and Exchange Commission adopted amendments to its recently enacted rules regarding proxy statement disclosure of executive and director compensation.
Read the complete article by clicking on the link below.
Related Insights
06 November 2024
November 2024 Midwest Cyber Security Alliance Meeting | Resilience Awakens: Tapping Into Your Inner Force for Managing Stress Effectively
Join us on Wednesday, November 20, 2024, for a very special Midwest Cyber Security Alliance meeting offering a unique, interactive approach to mental wellness, helping professionals thrive in high-stress environments like cybersecurity.
12 November 2024
Events
MEMA Original Equipment Suppliers Annual Conference 2024
Join Foley at the MEMA Original Equipment Suppliers Annual Conference on November 12-13.
05 November 2024
Health Care Law Today
Cancer Drugs: Clinical Trial Issues for Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Antibody Drug Conjugates (ADCs) are a class of small molecule drugs and an antibody conjugated together by a chemical linker.